5 Best Small Cap Pharma Stocks to Invest In

3. Pacira BioSciences, Inc. (NASDAQ:PCRX)

Number of Hedge Fund Investors In Q4 2023: 26

Pacira BioSciences, Inc. (NASDAQ:PCRX) is a specialty pharma small cap stock that focuses on making medicines that are used to make non opiod based pain management medicine. The firm was out with a key set of research data in February 2024 that saw its treatment outperform a rival in helping patients undergoing toe surgery to correct bunions.

By the end of this year’s fourth quarter, 26 out of the 933 hedge funds profiled by Insider Monkey were Pacira BioSciences, Inc. (NASDAQ:PCRX)’s investors. Jim Simons’ Renaissance Technologies owned the biggest stake which was worth $57.9 million.

Follow Pacira Biosciences Inc. (NASDAQ:PCRX)